Elevated CRP levels are associated with increased carotid atherosclerosis independent of visceral obesity

Atherosclerosis

Volumn 200, Issue 2, 2008, Pages 417-423

  Alizadeh Dehnavi, Reza ^a   de Roos, Albert ^a   Rabelink, Ton J ^a   van Pelt, Johannes ^a   Wensink, Maarten J ^a   Romijn, Johannes A ^a   Tamsma, Jouke T ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

3T MRI; Atherosclerosis; CRP; Visceral adipose tissue; Visceral obesity

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY FAT DISTRIBUTION; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; INFLAMMATION; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE;

ADIPOSE TISSUE; ANTHROPOMETRY; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBESITY; RISK;

EID: 52049120630     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.12.050     Document Type: Article

References (30)

1. Despres J.P., Lemieux I., and Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 322 (2001) 716-720
2. Van Gaal L.F., Vansant G.A., and De L.I. Upper body adiposity and the risk for atherosclerosis. J Am Coll Nutr 8 (1989) 504-514
3. Wong S., Janssen I., and Ross R. Abdominal adipose tissue distribution and metabolic risk. Sports Med 33 (2003) 709-726
4. Pascot A., Lemieux I., Prud'homme D., et al. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res 42 (2001) 2007-2014
5. Lemieux I., Pascot A., Prud'homme D., et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 21 (2001) 961-967
6. Tchernof A., Lamarche B., Prud'homme D., et al. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 19 (1996) 629-637
7. Reaven G.M. The metabolic syndrome: is this diagnosis necessary?. Am J Clin Nutr 83 (2006) 1237-1247
8. Abbasi F., Brown Jr. B.W., Lamendola C., McLaughlin T., and Reaven G.M. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 40 (2002) 937-943
9. Trayhurn P., and Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92 (2004) 347-355
10. Yudkin J.S., Stehouwer C.D., Emeis J.J., and Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 19 (1999) 972-978
11. Couillard C., Bergeron N., Prud'homme D., et al. Postprandial triglyceride response in visceral obesity in men. Diabetes 47 (1998) 953-960
12. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107 (2003) 363-369
13. Yusuf S., Hawken S., Ounpuu S., et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366 (2005) 1640-1649
14. Hak A.E., Stehouwer C.D., Bots M.L., et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 19 (1999) 1986-1991
15. Jarvisalo M.J., Harmoinen A., Hakanen M., et al. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol 22 (2002) 1323-1328
16. Blackburn R., Giral P., Bruckert E., et al. Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects. Arterioscler Thromb Vasc Biol 21 (2001) 1962-1968
17. Alizadeh Dehnavi R., Doornbos J., Tamsma J.T., et al. Assessment of the carotid artery by MRI at 3T: a study on reproducibility. J Magn Reson Imaging 25 (2007) 1035-1043
18. Saam T., Kerwin W.S., Chu B., et al. Sample size calculation for clinical trials using magnetic resonance imaging for the quantitative assessment of carotid atherosclerosis. J Cardiovasc Magn Reson 7 (2005) 799-808
19. Fredrikson G.N., Hedblad B., Nilsson J.A., Alm R., Berglund G., and Nilsson J. Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels. Metabolism 53 (2004) 1436-1442
20. Couillard C., Ruel G., Archer W.R., et al. Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab 90 (2005) 6454-6459
21. Pou K.M., Massaro J.M., Hoffmann U., et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham heart study. Circulation 116 (2007) 1234-1241
22. Timpson N.J., Lawlor D.A., Harbord R.M., et al. C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet 366 (2005) 1954-1959
23. Khera A., McGuire D.K., Murphy S.A., et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 46 (2005) 464-469
24. Shinnar M., Fallon J.T., Wehrli S., et al. The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. Arterioscler Thromb Vasc Biol 19 (1999) 2756-2761
25. Varghese A., Crowe L.A., Mohiaddin R.H., et al. Inter-study reproducibility of 3D volume selective fast spin echo sequence for quantifying carotid artery wall volume in asymptomatic subjects. Atherosclerosis 183 (2005) 361-366
26. Cury R.C., Houser S.L., Furie K.L., et al. Vulnerable plaque detection by 3.0 tesla magnetic resonance imaging. Invest Radiol 41 (2006) 112-115
27. Yarnykh V.L., Terashima M., Hayes C.E., et al. Multicontrast black-blood MRI of carotid arteries: Comparison between 1.5 and 3 tesla magnetic field strengths. J Magn Reson Imaging (2006)
28. Despres J.P., and Lemieux I. Abdominal obesity and metabolic syndrome. Nature 444 (2006) 881-887
29. Lemieux I., Drapeau V., Richard D., et al. Waist girth does not predict metabolic complications in severely obese men. Diabetes Care 29 (2006) 1417-1419
30. Koenig W., Lowel H., Baumert J., and Meisinger C. C-reactive protein modulates risk prediction based on the Framingham score: implications for future risk assessment: results from a large cohort study in Southern Germany. Circulation 109 (2004) 1349-1353